Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GlaxoSmithKline Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 126.76B | 28.1x | 0.11 | PKR 398.02 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbott Laboratories Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 105.73B | 21.1x | 0.01 | PKR 1,079.99 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Haleon Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 93.99B | 20.5x | 0.06 | PKR 803 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Searle Company | Karachi | Healthcare | Pharmaceuticals | PKR 49.76B | -23.7x | -0.05 | PKR 97.29 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGP | Karachi | Healthcare | Pharmaceuticals | PKR 48.71B | 23.6x | 0.61 | PKR 173.98 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.5% Upside | Upgrade to Pro+ | |
Highnoon Labs | Karachi | Healthcare | Pharmaceuticals | PKR 44.93B | 14.9x | 0.75 | PKR 848.05 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hoechst Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 30.81B | 19x | 0.01 | PKR 3,194 | 6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Citi Pharma | Karachi | Healthcare | Pharmaceuticals | PKR 23.28B | 23.3x | 0.44 | PKR 99.99 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BF Biosciences | Karachi | Healthcare | Pharmaceuticals | PKR 18.80B | 38.5x | PKR 190.11 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -49.7% Downside | Upgrade to Pro+ | ||
Ferozsons Labs | Karachi | Healthcare | Pharmaceuticals | PKR 15.26B | 23.8x | 0.41 | PKR 351 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macter International | Karachi | Healthcare | Pharmaceuticals | PKR 14.08B | 14.6x | PKR 307.42 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Liven Pharma | Karachi | Healthcare | Pharmaceuticals | PKR 9.86B | 9.1x | 0.14 | PKR 106 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Otsuka Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 2.40B | -15x | -6.85 | PKR 198.25 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |